Eva Montgomerie

Head of Accounting at Karolinska Development AB

Eva Montgomerie

Eva Montgomerie

Head of Accounting at Karolinska Development AB

Overview
RelSci Relationships

66

Birthday

1958

Age

60

Relationships
RelSci Relationships are individuals Eva Montgomerie likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at KDev Exploratory AB

Relationship likelihood: Strong

General Counsel at Karolinska Development AB

Relationship likelihood: Strong

Former Managing Director at Novo Nordisk Fonden

Relationship likelihood: Strong

Director, Intellectual Property & Senior Patent Attorney EPA at Axelar AB

Relationship likelihood: Strong

President Asia at Karolinska Development AB

Relationship likelihood: Strong

Chief Executive Officer at Karolinska Development AB

Relationship likelihood: Strong

Senior Scientist at Johnson & Johnson

Relationship likelihood: Average

Chief Financial Officer at Karolinska Development AB

Relationship likelihood: Average

Senior Advisor at Lipidor AB

Relationship likelihood: Average

Former Director for Exploratory Research in Oncology, R&D Center at Boehringer Ingelheim GmbH

Relationship likelihood: Average

Paths to Eva Montgomerie
Potential Connections via
Relationship Science
You
Eva Montgomerie
Head of Accounting at Karolinska Development AB
Career History
Head of Accounting
2007 - Current

Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments. The company was founded in 2006 and is headquartered in Solna, Sweden.

Head-Administration
Current

KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden.

Finance Manager
Prior

Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eva Montgomerie. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eva Montgomerie's profile does not indicate a business or promotional relationship of any kind between RelSci and Eva Montgomerie.